Sign in

CIK 0001404644 · Non-accelerated filer<br>Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
980542593
Phone
(877) 237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
  1. DEF 14A Proxy Proxy Statement
  2. DEF 14A Proxy Proxy Statement
  3. DEF 14A Proxy Proxy Statement
  4. DEF 14A Proxy Proxy Statement
  5. PRE 14A Proxy Proxy Statement (Preliminary)
  6. DEF 14A Proxy Proxy Statement
  7. DEF 14A Proxy Proxy Statement
  8. DEF 14A Proxy Proxy Statement
  9. DEF 14A Proxy Proxy Statement
  10. PRE 14A Proxy Proxy Statement (Preliminary)
  11. DEF 14A Proxy Proxy Statement
  12. DEF 14A Proxy Proxy Statement
  13. DEF 14A Proxy Proxy Statement
  14. DEF 14A Proxy Proxy Statement

Page 1 of 1 · 14 filings